Jill O’Donnell-Tormey, Ph.D.
Dr. Jill O’Donnell-Tormey leads the Cancer Research Institute (CRI), a global nonprofit organization dedicated to investing in the most promising areas of cancer immunotherapy research to harness the power of the immune system to conquer and cure all cancers. Dr. O’Donnell-Tormey joined the organization in 1987 as director of scientific affairs and began serving as its chief executive in 1993. During her tenure at CRI, she has helped to create catalytic and novel research programs that span the laboratory and the clinic. She has guided over $380 million in funding to these programs, which enable the research and scientific discoveries changing the course of cancer treatment today. Dr. O’Donnell-Tormey began her career as a postdoctoral fellow in the laboratory of cellular physiology and immunology at The Rockefeller University and proceeded to work as a research associate in the Department of Medicine at Cornell University Medical College.
Dr. O’Donnell-Tormey received a Bachelor of Science degree in chemistry, summa cum laude, from Fairleigh Dickinson University, and a Doctor of Philosophy in cell biology from the SUNY Downstate Medical Center. She sits on the boards of HemaCare, the SFO-Science Foundation for Oncology, Zurich, Switzerland; The City University of New York (CUNY); Richmond University Medical Center; and, the Staten Island Foundation.